Centiva Capital’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $413K | Buy |
+20,303
| New | +$413K | 0.01% | 765 |
|
|
2023
Q4 | – | Sell |
-9,727
| Closed | -$268K | – | 1308 |
|
|
2023
Q3 | $268K | Buy |
+9,727
| New | +$268K | 0.01% | 804 |
|
|
2018
Q4 | – | Sell |
-8,115
| Closed | -$55K | – | 108 |
|
|
2018
Q3 | $55K | Sell |
8,115
-4,402
| -35% | -$29.8K | ﹤0.01% | 43 |
|
|
2018
Q2 | $95K | Buy |
+12,517
| New | +$95K | 0.02% | 18 |
|